Treatment of peripapillary choroidal neovascularization with intravitreal bevacizumab

European Journal of Ophthalmology

Volumn 19, Issue 1, 2009, Pages 163-165

  Hoeh, A E ^a   Schaal, K B ^a   Ach, T ^a   Dithmar, Stefan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Bevacizumab; Peripapillary choroidal neovascularization; VEGF

Indexed keywords

BEVACIZUMAB;

AGED; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; METAMORPHOSIS; OPTIC DISK; OPTICAL COHERENCE TOMOGRAPHY; PERIPAPILLARY SUBRETINAL NEOVASCULARIZATION; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; SCOTOMA; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MALE; OPTIC DISK; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 69249109304     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900128     Document Type: Article

References (6)

1. Browning DJ, Fraser CM. Ocular conditions associated with peripapillary subretinal neovascularization, their relative frequencies, and associated outcomes. Ophthalmology 2005; 112: 1054-61.
2. Lopez PF, Green WR. Peripapillary subretinal neovascularization. A review. Retina 1992; 12: 147-71.
3. The Macular Photocoagulation Study Group. Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Arch Ophthalmol 1995; 113: 56-61.
4. Rosenblatt BJ, Shah GK, Blinder K. Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization. Retina 2005; 25: 33-7.
5. Soliman W, Lund-Andersen H, Larsen M. Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization. Acta Ophthalmol Scand 2006; 84: 707-8.
6. Spandau UHM, Jonas JB. Intravitreal bevacizumab for peripapillary classic subretinal neovascularisation. Acta Ophthalmol Scand 2007; 85: 340-1.